Clovis Oncology, Inc. (CLVS) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Clovis Oncology, Inc. (CLVS) - Medical Equipment - Deals and Alliances Profile

Clovis Oncology, Inc. (CLVS) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Clovis Oncology, Inc. (CLVS) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
40 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Clovis Oncology, Inc. (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercializes rights for rociletinib, rucaparib and holds right in U.S. and Japan for lucitanib. The company has collaboration agreements with various companies such as Celgene Avilomics Research Inc.; Advenchen Laboratories LLC; Pfizer Inc. and Les Laboratoires Servier for the development and commercialization of its product candidates.

Clovis Oncology, Inc. (CLVS) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summa

  
Source:
Document ID
GDME189107D
Country
Industry
Ticker
CLVS=US
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Clovis Oncology, Inc., Medical Equipment, Deals By Year, 2010 to YTD 201642
Clovis Oncology, Inc., Medical Equipment Deals By Type, 2010 to YTD 201661
Clovis Oncology, Inc., Medical Equipment, Deals By Region, 2010 to YTD 201671
Clovis Oncology, Inc., Medical Equipment, Deals By Market, 2010 to YTD 201681
Clovis Oncology, Inc., Medical Equipment, Deals Summary, 2010 to YTD 201691
Clovis Oncology, Inc., Medical Equipment, Deal Details1010
  Partnerships101
    Foundation Medicine Extends Co-Development Agreement With Clovis Oncology102
    Clovis Oncology Enters Into Co-Development Agreement With Qiagen122
    Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology141
    Clovis Oncology Enters Into Co-Development Agreement With Array BioPharma151
    Roche Enters Into Co-Development Agreement With Clovis Oncology161
    Clovis Oncology Enteres Into Co-Development Agreement With Ventana Medical Systems171
  Equity Offering181
    Clovis Oncology Completes Public Offering Of Shares For US$262 Million182
Clovis Oncology, Inc. - Key Competitors201
Key Employees211
Locations And Subsidiaries221
  Head Office221
  Other Locations &Subsidiaries221
Recent Developments231
Financial Announcements231
Aug 08, 2016: Clovis Oncology Announces Q2 2016 Operating Results and Corporate Update232
May 05, 2016: Clovis Oncology Announces Q1 2016 Operating Results and Corporate Update252
Feb 25, 2016: Clovis Oncology Announces 2015 Operating Results272
Nov 05, 2015: Clovis Oncology Announces Third Quarter 2015 Operating Results292
Aug 06, 2015: Clovis Oncology Announces Second Quarter 2015 Operating Results312
May 06, 2015: Clovis Oncology Announces First Quarter 2015 Operating Results333
Feb 25, 2015: Clovis Oncology Announces 2014 Operating Results363
Corporate Communications391
Jun 22, 2015: Clovis Oncology Appoints Dr. Lindsey Rolfe As Chief Medical Officer391
Appendix401
  Methodology401
  About GlobalData401
  Contact Us401
  Disclaimer401

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Clovis Oncology, Inc. (CLVS) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Clovis-Oncology-Inc-CLVS-Medical-Equipment-Deals-and-Alliances-Profile-2148-9402>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Clovis Oncology, Inc. (CLVS) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Clovis-Oncology-Inc-CLVS-Medical-Equipment-Deals-and-Alliances-Profile-2148-9402>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research